Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Resectable Esophageal Cancer × Cetuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 39 Squamous Cell Carcinoma of Head and Neck 18 Head and Neck Neoplasms 17 Rectal Neoplasms 14 Colonic Neoplasms 13 Neoplasms 9 Neoplasm Metastasis 9 Carcinoma, Squamous Cell 9 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 5 Recurrence 4 Esophageal Neoplasms 4 Laryngeal Neoplasms 3 Tongue Neoplasms 2 Stomach Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Squamous Cell 2 Mouth Neoplasms 2 Lung Neoplasms 2 Laryngeal Diseases 2 Glioma 2 Glioblastoma 2 Colorectal Cancer Metastatic 2 Breast Neoplasms 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 Salivary Gland Neoplasms 1 Resectable Esophageal Cancer 1 Pharyngeal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00827671 2018-03-09

TRACC

UMC Utrecht

Phase 2 Terminated

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡